BioSpace News Archive

Press Releases

Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights

March 26, 2026
·
13 min read
Press Releases

HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics

March 26, 2026
·
2 min read
Press Releases

BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD

March 26, 2026
·
6 min read
Press Releases

Peritia Appoints Michael A. Griffith as Chief Executive Officer

March 26, 2026
·
2 min read
Press Releases

Sitryx to participate in upcoming April 2026 investor conferences

March 26, 2026
·
1 min read
Press Releases

Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007

March 26, 2026
·
13 min read
Press Releases

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

March 26, 2026
·
12 min read
Press Releases

Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update

March 26, 2026
·
15 min read
Press Releases

Cognition Therapeutics Reports Year End 2025 Financial Results and Provides Clinical Development Update

March 26, 2026
·
10 min read
Press Releases

Plus Therapeutics Appoints Diagnostics and Molecular Diagnostics Industry Leader Ron Andrews to its Board of Directors

March 26, 2026
·
6 min read